Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J. Hsieh, Robert J. Motzer, Almedina Redzematovic et al.|European Urology|2016Cited by 204
Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next generation sequencing (NGS): Results from RECORD-3.James J. Hsieh, Robert J. Motzer, David Chen et al.|Journal of Clinical Oncology|2015Cited by 26